• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Patients with checkpoint inhibitor-induced inflammatory arthritis do not become seropositive for anti-cyclic citrullinated peptide when followed over time.

作者信息

Cappelli Laura C, Darrah Erika, Shah Ami A, Bingham Clifton O

机构信息

Johns Hopkins University School of Medicine, Baltimore, MD.

出版信息

ACR Open Rheumatol. 2022 Jan;4(1):83-84. doi: 10.1002/acr2.11363. Epub 2021 Nov 10.

DOI:10.1002/acr2.11363
PMID:34757698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8754020/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5081/8754020/7c11697d4a54/ACR2-4-83-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5081/8754020/7c11697d4a54/ACR2-4-83-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5081/8754020/7c11697d4a54/ACR2-4-83-g001.jpg

相似文献

1
Patients with checkpoint inhibitor-induced inflammatory arthritis do not become seropositive for anti-cyclic citrullinated peptide when followed over time.随着时间推移，接受检查点抑制剂治疗引发炎症性关节炎的患者不会出现抗环瓜氨酸肽血清学阳性。
ACR Open Rheumatol. 2022 Jan;4(1):83-84. doi: 10.1002/acr2.11363. Epub 2021 Nov 10.
2
[The prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.].[抗环瓜氨酸肽抗体在幼年特发性关节炎中的患病率。]
J Pediatr (Rio J). 2005 Nov-Dec;81(6):491-4. doi: 10.2223/JPED.1397. Epub 2005 Nov 30.
3
Comparison of two assays to determine anti-citrullinated peptide antibodies in rheumatoid arthritis in relation to other chronic inflammatory rheumatic diseases: assaying anti-modified citrullinated vimentin antibodies adds value to second-generation anti-citrullinated cyclic peptides testing.比较两种方法来检测类风湿关节炎中的抗瓜氨酸化肽抗体与其他慢性炎症性风湿病的关系：检测抗修饰的瓜氨酸化波形蛋白抗体增加了第二代抗瓜氨酸化环肽检测的价值。
Biomed Res Int. 2014;2014:198198. doi: 10.1155/2014/198198. Epub 2014 Jun 15.
4
Early prediction of rheumatoid arthritis by magnetic resonance imaging in the absence of anti-cyclic citrullinated peptide antibodies and radiographic erosions in undifferentiated inflammatory arthritis patients: a prospective study.在未分化型炎性关节炎患者中，在无抗环瓜氨酸肽抗体和影像学侵蚀的情况下，通过磁共振成像对类风湿性关节炎进行早期预测：一项前瞻性研究。
Int J Rheum Dis. 2015 Nov;18(8):859-65. doi: 10.1111/1756-185X.12420. Epub 2014 Dec 5.
5
[The prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis].[抗环瓜氨酸肽抗体在幼年特发性关节炎中的患病率]
J Pediatr (Rio J). 2005 Nov-Dec;81(6):491-4. doi: 10.2223/JPED.1397.
6
Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.炎性肠病和相关关节炎中的抗突变瓜氨酸化波形蛋白抗体和抗环瓜氨酸肽抗体。
Inflamm Bowel Dis. 2012 Sep;18(9):1655-62. doi: 10.1002/ibd.21937. Epub 2011 Nov 23.
7
Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?非类风湿性关节炎疾病样本中抗环瓜氨酸肽阳性：是否依赖瓜氨酸？
Ann Rheum Dis. 2007 Apr;66(4):511-6. doi: 10.1136/ard.2006.058933. Epub 2006 Sep 19.
8
Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.与第二代抗环瓜氨酸肽和类风湿因子相比，抗瓜氨酸化波形蛋白和第三代抗环瓜氨酸肽在预测未分化关节炎和类风湿关节炎疾病转归中的价值。
Arthritis Rheum. 2009 Aug;60(8):2232-41. doi: 10.1002/art.24716.
9
Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.抗瓜氨酸化蛋白抗体水平与类风湿关节炎中抗Sa（瓜氨酸化波形蛋白）抗体水平相关。
J Rheumatol. 2016 Feb;43(2):273-281. doi: 10.3899/jrheum.150179. Epub 2015 Dec 15.
10
Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.检测类风湿关节炎患者中针对瓜氨酸化 BiP 的自身抗体及瓜氨酸化 BiP 在胶原诱导性关节炎中的促炎作用。
Arthritis Res Ther. 2011;13(6):R191. doi: 10.1186/ar3520. Epub 2011 Nov 22.

引用本文的文献

1
Immune checkpoint inhibitor-induced inflammatory arthritis.免疫检查点抑制剂诱导的炎性关节炎。
Clin Med (Lond). 2025 Aug 6;25(5):100496. doi: 10.1016/j.clinme.2025.100496.
2
Two clinical subgroups of immune checkpoint inhibitor-induced inflammatory arthritis determined by latent class analysis.通过潜在类别分析确定的免疫检查点抑制剂诱导的炎性关节炎的两个临床亚组。
Semin Arthritis Rheum. 2025 Jun 19;74:152773. doi: 10.1016/j.semarthrit.2025.152773.
3
Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?免疫检查点抑制剂与类风湿关节炎：条条大路通PD-1？

本文引用的文献

1
Rheumatic immune-related adverse events associated with cancer immunotherapy: A nationwide multi-center cohort.与癌症免疫治疗相关的风湿免疫相关不良事件：一项全国多中心队列研究。
Autoimmun Rev. 2020 Aug;19(8):102595. doi: 10.1016/j.autrev.2020.102595. Epub 2020 Jun 11.
2
Checkpoint Inhibitor-Associated Arthritis: A Systematic Review of Case Reports and Case Series.免疫检查点抑制剂相关性关节炎：病例报告和病例系列的系统评价。
J Clin Rheumatol. 2021 Dec 1;27(8):e317-e322. doi: 10.1097/RHU.0000000000001370.
3
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation.
Semin Arthritis Rheum. 2025 Feb;70S:152582. doi: 10.1016/j.semarthrit.2024.152582. Epub 2024 Nov 14.
4
Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy.癌症免疫治疗中免疫检查点抑制剂的风湿性不良事件。
Expert Rev Clin Immunol. 2024 Aug;20(8):873-893. doi: 10.1080/1744666X.2024.2323966. Epub 2024 Mar 19.
5
Updates in toxicities associated with immune checkpoint inhibitors.免疫检查点抑制剂相关毒性的最新进展。
Expert Rev Clin Immunol. 2023 Jul-Dec;19(9):1117-1129. doi: 10.1080/1744666X.2023.2221434. Epub 2023 Jun 5.
6
Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis.抗 RA33 抗体存在于一部分免疫检查点抑制剂诱导的炎症性关节炎患者中。
RMD Open. 2022 Sep;8(2). doi: 10.1136/rmdopen-2022-002511.
7
Monitoring and Management of the Patient with Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis: Current Perspectives.免疫检查点抑制剂诱导的炎性关节炎患者的监测与管理：当前观点
J Inflamm Res. 2022 May 25;15:3105-3118. doi: 10.2147/JIR.S282600. eCollection 2022.
免疫检查点抑制剂诱导的炎症性关节炎在免疫治疗停止后仍然存在。
Ann Rheum Dis. 2020 Mar;79(3):332-338. doi: 10.1136/annrheumdis-2019-216109. Epub 2019 Sep 20.
4
Rheumatic immune-related adverse events in patients on anti-PD-1 inhibitors: Fasciitis with myositis syndrome as a new complication of immunotherapy.抗 PD-1 抑制剂治疗患者的风湿免疫相关不良事件：肌炎综合征伴筋膜炎作为免疫治疗的一种新并发症。
Autoimmun Rev. 2018 Oct;17(10):1040-1045. doi: 10.1016/j.autrev.2018.05.002. Epub 2018 Aug 10.
5
Immune checkpoint blockade: a common denominator approach to cancer therapy.免疫检查点阻断：癌症治疗的一种通用方法。
Cancer Cell. 2015 Apr 13;27(4):450-61. doi: 10.1016/j.ccell.2015.03.001. Epub 2015 Apr 6.
6
High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis.高抗环瓜氨酸肽（CCP）抗体滴度预示着活动性类风湿关节炎患者对利妥昔单抗治疗反应良好。
Joint Bone Spine. 2014 Oct;81(5):416-20. doi: 10.1016/j.jbspin.2014.06.001. Epub 2014 Jul 3.